| Legionnaires' disease: description of an epidemic of pneumonia DW Fraser, TR Tsai, W Orenstein, WE Parkin, HJ Beecham, RG Sharrar, ... New England Journal of Medicine 297 (22), 1189-1197, 1977 | 2491 | 1977 |
| Vaccines SA Plotkin, WA Orenstein, PA Offit Elsevier Health Sciences, 2008 | 1436 | 2008 |
| Vaccine refusal, mandatory immunization, and the risks of vaccine-preventable diseases SB Omer, DA Salmon, WA Orenstein, MP Dehart, N Halsey New England Journal of Medicine 360 (19), 1981-1988, 2009 | 1291 | 2009 |
| Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection Committee on Infectious Diseases and Bronchiolitis Guidelines Committee Pediatrics 134 (2), e620-e638, 2014 | 854* | 2014 |
| Field evaluation of vaccine efficacy. WA Orenstein, RH Bernier, TJ Dondero, AR Hinman, JS Marks, KJ Bart, ... Bulletin of the World Health Organization 63 (6), 1055, 1985 | 727 | 1985 |
| Measles antibody: reevaluation of protective titers RT Chen, LE Markowitz, P Albrecht, JA Stewart, LM Mofenson, ... Journal of infectious diseases 162 (5), 1036-1042, 1990 | 706 | 1990 |
| Assessing vaccine efficacy in the field: further observations WA ORENSTEIN, RH BERNIER, AR HINMAN Epidemiologic reviews 10 (1), 212-241, 1988 | 491 | 1988 |
| Epidemiology of poliomyelitis in the United States one decade after the last reported case of indigenous wild virus-associated disease PM Strebel, RW Sutter, SL Cochi, RJ Biellik, EW Brink, OM Kew, ... Clinical infectious diseases 14 (2), 568-579, 1992 | 424 | 1992 |
| Prevention of respiratory syncytial virus infections: indications for the use of palivizumab and update on the use of RSV-IGIV NA Halsey, JS Abramson, PJ Chesney, MC Fisher, MA Gerber, SM Marcy, ... Pediatrics 102 (5), 1211-1216, 1998 | 422 | 1998 |
| Measles vaccine PM Strebel, MJ Papania, AP Fiebelkorn, NA Halsey, S Plotkin, ... Vaccines 6, 352-87, 2012 | 415 | 2012 |
| Simply put: Vaccination saves lives WA Orenstein, R Ahmed Proceedings of the National Academy of Sciences 114 (16), 4031-4033, 2017 | 406 | 2017 |
| Vaccine-associated paralytic poliomyelitis: United States: 1973 through 1984 BM Nkowane, SGF Wassilak, WA Orenstein, KJ Bart, LB Schonberger, ... Jama 257 (10), 1335-1340, 1987 | 396 | 1987 |
| Rubella N Lambert, P Strebel, W Orenstein, J Icenogle, GA Poland The Lancet 385 (9984), 2297-2307, 2015 | 394 | 2015 |
| The yellow fever virus vaccine induces a broad and polyfunctional human memory CD8+ T cell response RS Akondy, ND Monson, JD Miller, S Edupuganti, D Teuwen, H Wu, ... The Journal of Immunology 183 (12), 7919-7930, 2009 | 369 | 2009 |
| The immunization system in the United States—the role of school immunization laws WA Orenstein, AR Hinman Vaccine 17, S19-S24, 1999 | 363 | 1999 |
| From the American Academy of Pediatrics: Policy statements--Modified recommendations for use of palivizumab for prevention of respiratory syncytial virus infections Committee on Infectious Diseases Pediatrics 124 (6), 1694-1701, 2009 | 361* | 2009 |
| Policy statement: recommendations for the prevention of pneumococcal infections, including the use of pneumococcal conjugate vaccine (Prevnar), pneumococcal polysaccharide … Committee on Infectious Diseases Pediatrics 106 (2), 362-366, 2000 | 350 | 2000 |
| Strategies for prevention of health care–associated infections in the NICU RA Polin, S Denson, MT Brady, ... Pediatrics 129 (4), e1085-e1093, 2012 | 324* | 2012 |
| Clostridium difficile Infection in Infants and Children Committee on Infectious Diseases, GE Schutze, RE Willoughby, MT Brady, ... Pediatrics 131 (1), 196-200, 2013 | 322 | 2013 |
| Polio vaccination: past, present and future AS Bandyopadhyay, J Garon, K Seib, WA Orenstein Future microbiology 10 (5), 791-808, 2015 | 320 | 2015 |
